HOME >> MEDICINE >> NEWS
Drug treatment improves learning in mice with Down syndrome symptoms, Stanford/Packard study shows

STANFORD, Calif. -- A once-a-day, short-term treatment with a drug compound substantially improved learning and memory in mice with Down syndrome symptoms, say researchers at the Stanford University School of Medicine and Lucile Packard Childrens Hospital. Whats more, the gains lasted for months after the treatment was discontinued. The researchers are now considering a clinical trial to test whether the compound has a similar effect in humans with Down syndrome.

"This treatment has remarkable potential," said Craig Garner, PhD, professor of psychiatry and behavioral sciences and co-director of Stanfords Down Syndrome Research Center. "So many other drugs have been tried that had no effect all. Our findings clearly open a new avenue for considering how cognitive dysfunction in individuals with Down syndrome might be treated." The center was created by researchers at Stanford and Packard Childrens in 2003 to rapidly translate research discoveries into useful treatments for people with Down syndrome.

The research, which will be published Feb. 25 in the advance online edition of Nature Neuroscience, was conducted by Fabian Fernandez, a graduate student in Garners laboratory. Fernandez found that affected mice were significantly better able to identify novel objects and navigate a maze tasks that simulate difficulties faced by children and adults with Down syndrome after being fed 17 daily doses of milk containing a compound called pentylenetetrazole, or PTZ. Treated mice performed as well as their wild-type counterparts for up to two months after drug treatment was discontinued.

"Somehow the drug treatment creates a new capacity for learning," said Garner, who cautions that this new ability may decay over longer periods of time as older, drug-experienced neurons are replaced by younger cells.

The researchers believe that the key to the improvement lies in the fact that PTZ blocks the action of an inhibitory neurotransmitter
'"/>

Contact: Louis Bergeron
louisb3@stanford.edu
650-723-0272
Stanford University Medical Center
25-Feb-2007


Page: 1 2 3 4

Related medicine news :

1. Spot on treatment for acne
2. New treatment boosts muscle function in myasthenia gravis
3. New treatment effective in counteracting cocaine-induced symptoms
4. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
5. Preventive treatments in elderly people needs rethinking
6. Osteoporosis screening and treatment may be cost-effective for selected older men
7. Quality of treatment guidelines
8. Green tea holds promise as new treatment for inflammatory skin diseases
9. Many heart attack patients still not getting emergency clot-busting treatment
10. Electric fields have potential as a cancer treatment
11. New algorithm matches any tumor cells to best possible anti-cancer treatments

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/13/2018)... , ... September 13, 2018 , ... The Kelly ... organization that operates the largest shelter for women and children experiencing homelessness in the ... which was developed to keep the red doors of Saint John’s open after the ...
(Date:9/12/2018)... ... September 12, 2018 , ... Definitive Healthcare , the ... third annual golf tournament supporting the Dana-Farber Cancer Institute and the Jimmy Fund. ... Caccavaro, the tournament director. “I’m happy we have such wonderful sponsors and volunteers. The ...
(Date:9/7/2018)... ... 07, 2018 , ... Start your engines and race to the new ... to choose. Pedal power is the name of the game here – whether it’s ... on the miniature Indianapolis Motor Speedway oval. , The timing couldn’t be better with ...
(Date:9/2/2018)... ... September 01, 2018 , ... ... HydraFacial MD® Elite to its leading menu of results-driven aesthetic treatments. HydraFacial ... an infusion of clinically-proven ingredients to dramatically improve your skin’s tone and ...
(Date:9/1/2018)... ... 2018 , ... Alice Branton shared her personal story on NBC Daytime about ... Jerry Penacoli. , With all the medical advancements over the last hundred years, ... public health problem worldwide irrespective of age, location, ethnicity, and gender. Even in those ...
Breaking Medicine News(10 mins):
(Date:9/12/2018)... ... September 13, 2018 , ... Safety ... Sept. 27, 2018 — 1:30 p.m. – 3:00 p.m. ET, http://info.fdanews.com/safety-reporting-in-global-clinical-trials ... by as much as fifty percent. , This can be due to ...
(Date:9/7/2018)... ... 2018 , ... This year, the California Society of Plastic Surgeons (CSPS) awarded ... IMPLANT® - Seven-Year Clinical Trial Results at the 68th CSPS Annual Meeting. Dr. ... (American Society of Plastic Surgeons) meeting in Chicago this fall. , “I am honored ...
(Date:9/7/2018)... ... ... Pastor and Overseer at The House of Yahweh in Abilene, Texas, has written a new ... is undeniable. , Yisrayl scolds mainstream religions for allowing and even promoting the use of ... great meaning in the Name, and to take that away, shows there is an intentional ...
Breaking Medicine Technology:
Cached News: